Pseudomembranous Colitis Caused by C. Difficile

Overview

Journal Curr Treat Options Gastroenterol

Specialty Gastroenterology

Date 2000 Nov 30

PMID 11097737

Authors

Surawicz

McFarland

Affiliations

Soon will be listed here.

Abstract

Pseudomembranous colitis (PMC) is a considerable clinical concern for several reasons, including disease severity, increasing frequency, complications, and development of antibiotic-resistant organisms. C. difficile infection should be considered in anyone who develops diarrhea during or after antibiotic therapy; PMC is the most serious manifestation of C. difficile disease. PMC is effectively treated with either metronidazole or vancomycin. Metronidazole should be first-line therapy, reserving vancomycin for those who are very ill or who do not respond to metronidazole or cannot take it (ie, first trimester pregnancy, side effects). Recurrent C. difficile disease (which occurs in approximately 20% of C. difficile cases) is best treated with an antibiotic in combination with a biotherapeutic agent. Prevention of epidemics of C. difficile requires careful hand washing and cleaning of environmental surfaces. Antibiotic restriction may be necessary in some cases.

References

Bignardi G . Risk factors for Clostridium difficile infection. J Hosp Infect. 1998; 40(1):1-15. DOI: 10.1016/s0195-6701(98)90019-6. View

Frost F, Craun G, Calderon R . Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease. Emerg Infect Dis. 1998; 4(4):619-25. PMC: 2640242. DOI: 10.3201/eid0404.980412. View

Lofgren R, Tadlock L, Soltis R . Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis. Arch Intern Med. 1984; 144(3):617-9. View

Lipsett P, Samantaray D, Tam M, Bartlett J, Lillemoe K . Pseudomembranous colitis: a surgical disease?. Surgery. 1994; 116(3):491-6. View

Triadafilopoulos G, Hallstone A . Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology. 1991; 101(3):685-91. DOI: 10.1016/0016-5085(91)90526-q. View

Barbut F, Beaugerie L, Delas N, Aygalenq P, Petit J . Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients. Infectious Colitis Study Group. Clin Infect Dis. 1999; 29(2):356-60. DOI: 10.1086/520215. View

Brooks S, Veal R, Kramer M, Dore L, Schupf N, Adachi M . Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol. 1992; 13(2):98-103. DOI: 10.1086/646480. View

Lam S, Singer C, Tucci V, Morthland V, Pfaller M, ISENBERG H . The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control. 1995; 23(3):170-80. DOI: 10.1016/0196-6553(95)90038-1. View

McFarland L, Surawicz C, Greenberg R, FEKETY R, Elmer G, Moyer K . A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994; 271(24):1913-8. View

10.

Brandt L, Kosche K, Greenwald D, Berkman D . Clostridium difficile-associated diarrhea in the elderly. Am J Gastroenterol. 1999; 94(11):3263-6. DOI: 10.1111/j.1572-0241.1999.01534.x. View

11.

Gorecki P, SCHEIN M, Rucinski J, Wise L . Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues. World J Surg. 1999; 23(5):429-32; discussion 433. DOI: 10.1007/pl00012319. View

12.

Butterworth S, Koppert E, Clarke A, Wiggs B, Macfarlane J . Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility. Am J Surg. 1998; 175(5):403-7. DOI: 10.1016/S0002-9610(98)00058-0. View

13.

Kralovich K, Sacksner J, Eggenberger J . Pseudomembranous colitis with associated fulminant ileitis in the defunctionalized limb of a jejunal-ileal bypass. Report of a case. Dis Colon Rectum. 1997; 40(5):622-4. DOI: 10.1007/BF02055391. View

14.

Wilcox M . Treatment of Clostridium difficile infection. J Antimicrob Chemother. 1998; 41 Suppl C:41-6. DOI: 10.1093/jac/41.suppl_3.41. View

15.

Biller J, Katz A, Flores A, Buie T, Gorbach S . Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995; 21(2):224-6. DOI: 10.1097/00005176-199508000-00016. View

16.

Bradbury A, Barrett S . Surgical aspects of Clostridium difficile colitis. Br J Surg. 1997; 84(2):150-9. View

17.

McFarland L, Surawicz C, Greenberg R, Bowen K, Melcher S, Mulligan M . Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections. Am J Infect Control. 1999; 27(3):301-3. DOI: 10.1053/ic.1999.v27.a90941. View

18.

Zafar A, GAYDOS L, Furlong W, Nguyen M, Mennonna P . Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control. 1998; 26(6):588-93. DOI: 10.1053/ic.1998.v26.a84773. View

19.

Boland G, Lee M, Cats A, Mueller P . Pseudomembranous colitis: diagnostic sensitivity of the abdominal plain radiograph. Clin Radiol. 1994; 49(7):473-5. DOI: 10.1016/s0009-9260(05)81744-1. View

20.

Surawicz C, McFarland L . Pseudomembranous colitis: causes and cures. Digestion. 1999; 60(2):91-100. DOI: 10.1159/000007633. View